» Articles » PMID: 34585843

Seropositive Rheumatoid Arthritis After Vaccination Against SARS-CoV-2 Infection

Overview
Journal Int J Rheum Dis
Specialty Rheumatology
Date 2021 Sep 29
PMID 34585843
Citations 22
Authors
Affiliations
Soon will be listed here.
Citing Articles

The Possible Genetic and Environmental Factors Related to Behçet's Disease: Trisomy 8 and SARS-CoV-2.

Yoshimi R Intern Med. 2024; 64(1):3-5.

PMID: 39428520 PMC: 11781940. DOI: 10.2169/internalmedicine.4645-24.


New-onset Seropositive Rheumatoid Arthritis Post-mRNA COVID-19 Vaccine: A Case Report.

Almouslem A, Al Lawati T, Shirawi A, Al Amri U Oman Med J. 2024; 39(4):e597.

PMID: 38410178 PMC: 10895335. DOI: 10.5001/omj.2024.06.


New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review.

Nune A, Durkowski V, Pillay S, Barman B, Elwell H, Bora K Vaccines (Basel). 2023; 11(10).

PMID: 37896974 PMC: 10610967. DOI: 10.3390/vaccines11101571.


Development of Peptic Ulcer following Second Shot of Sputnik V Vaccine: A Case Report and Literature Review of Rare Side Effects of Sputnik V Vaccine.

Hasanzarrini M, Salehi A, Nirumandi Jahromi S Case Rep Infect Dis. 2023; 2023:9989515.

PMID: 37781635 PMC: 10539083. DOI: 10.1155/2023/9989515.


New-Onset Arthritis Following COVID-19 Vaccination: A Systematic Review of Case Reports.

Liu J, Wu H, Xia S Vaccines (Basel). 2023; 11(3).

PMID: 36992249 PMC: 10055862. DOI: 10.3390/vaccines11030665.


References
1.
Perrot L, Hemon M, Busnel J, Muis-Pistor O, Picard C, Zandotti C . First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 2021; 3(1):e6-e8. PMC: 7832430. DOI: 10.1016/S2665-9913(20)30396-9. View

2.
Baimukhamedov C, Barskova T, Matucci-Cerinic M . Arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 2021; 3(5):e324-e325. PMC: 7963449. DOI: 10.1016/S2665-9913(21)00067-9. View

3.
Ray P, Black S, Shinefield H, Dillon A, Carpenter D, Lewis E . Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age. Vaccine. 2011; 29(38):6592-7. DOI: 10.1016/j.vaccine.2011.06.112. View

4.
Magliulo D, Narayan S, Ue F, Boulougoura A, Badlissi F . Adult-onset Still's disease after mRNA COVID-19 vaccine. Lancet Rheumatol. 2021; 3(10):e680-e682. PMC: 8298008. DOI: 10.1016/S2665-9913(21)00219-8. View

5.
Logunov D, Dolzhikova I, Shcheblyakov D, Tukhvatulin A, Zubkova O, Dzharullaeva A . Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021; 397(10275):671-681. PMC: 7852454. DOI: 10.1016/S0140-6736(21)00234-8. View